ARGX · NASDAQ · Biotechnology

argenx (ADR) (ARGX)

Develops antibody medicines for severe autoimmune diseases around the VYVGART franchise.

$950.20
vs last close−13.59 (−1.41%)
  1. What Makes Argenx (ARGX) a New Buy Stock

    Zacks Investment Research